4//SEC Filing
Melnick David A. 4
Accession 0000899243-20-002618
CIK 0001701108other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:33 PM ET
Size
5.6 KB
Accession
0000899243-20-002618
Insider Transaction Report
Form 4
Melnick David A.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-02-03+55,000→ 55,000 totalExercise: $9.34Exp: 2030-02-03→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest as to 25% on February 3, 2021, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
Spero Therapeutics, Inc.
CIK 0001701108
Entity typeother
Related Parties
1- filerCIK 0001726485
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 5:33 PM ET
- Size
- 5.6 KB